177 related articles for article (PubMed ID: 36371196)
1. DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome.
Bradic M; Taleb S; Thomas B; Chidiac O; Robay A; Hassan N; Malek J; Ait Hssain A; Abi Khalil C
J Transl Med; 2022 Nov; 20(1):526. PubMed ID: 36371196
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic age acceleration in surviving versus deceased COVID-19 patients with acute respiratory distress syndrome following hospitalization.
Bejaoui Y; Humaira Amanullah F; Saad M; Taleb S; Bradic M; Megarbane A; Ait Hssain A; Abi Khalil C; El Hajj N
Clin Epigenetics; 2023 Nov; 15(1):186. PubMed ID: 38017502
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
5. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
7. Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Roehrig S; Ait Hssain A; Shallik NAH; Elsaid IMA; Mustafa SF; Smain OAM; Molokhia AA; Lance MD
Trials; 2020 Sep; 21(1):781. PubMed ID: 32917259
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
Corley MJ; Pang APS; Dody K; Mudd PA; Patterson BK; Seethamraju H; Bram Y; Peluso MJ; Torres L; Iyer NS; Premeaux TA; Yeung ST; Chandar V; Borczuk A; Schwartz RE; Henrich TJ; Deeks SG; Sacha JB; Ndhlovu LC
J Leukoc Biol; 2021 Jul; 110(1):21-26. PubMed ID: 33464637
[TBL] [Abstract][Full Text] [Related]
9. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
10. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
Guven BB; Erturk T; Kompe Ö; Ersoy A
Epidemiol Infect; 2021 Jun; 149():e137. PubMed ID: 34099076
[TBL] [Abstract][Full Text] [Related]
11. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
12. Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS.
Morales-Quinteros L; Neto AS; Artigas A; Blanch L; Botta M; Kaufman DA; Schultz MJ; Tsonas AM; Paulus F; Bos LD;
Crit Care; 2021 May; 25(1):171. PubMed ID: 34001222
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study.
Wang F; Ran L; Qian C; Hua J; Luo Z; Ding M; Zhang X; Guo W; Gao S; Gao W; Li C; Liu Z; Li Q; Ronco C
Blood Purif; 2021; 50(4-5):499-505. PubMed ID: 33291098
[TBL] [Abstract][Full Text] [Related]
14. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.
Konwar C; Asiimwe R; Inkster AM; Merrill SM; Negri GL; Aristizabal MJ; Rider CF; MacIsaac JL; Carlsten C; Kobor MS
Epigenetics Chromatin; 2021 Dec; 14(1):54. PubMed ID: 34895312
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.
Beloncle F; Studer A; Seegers V; Richard JC; Desprez C; Fage N; Merdji H; Pavlovsky B; Helms J; Cunat S; Mortaza S; Demiselle J; Brochard L; Mercat A; Meziani F
Crit Care; 2021 Jul; 25(1):248. PubMed ID: 34266454
[TBL] [Abstract][Full Text] [Related]
17. Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a rapid review.
Cumpstey AF; Oldman AH; Smith AF; Martin D; Grocott MP
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013708. PubMed ID: 32870512
[TBL] [Abstract][Full Text] [Related]
18. Segmental Lung Recruitment in Patients with Bilateral COVID-19 Pneumonia Complicated by Acute Respiratory Distress Syndrome: A Case Report.
Protić A; Bura M; Šustić A; Brusić J; Sotošek V
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676766
[TBL] [Abstract][Full Text] [Related]
19. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
20. Prone Positioning in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19: A Cohort Study and Analysis of Physiology.
Shelhamer MC; Wesson PD; Solari IL; Jensen DL; Steele WA; Dimitrov VG; Kelly JD; Aziz S; Gutierrez VP; Vittinghoff E; Chung KK; Menon VP; Ambris HA; Baxi SM
J Intensive Care Med; 2021 Feb; 36(2):241-252. PubMed ID: 33380236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
